Changing Landscape Of Ovarian Cancer Treatment: PARP Inhibitor Drugs Withdrawn For Some Indications

Dr. Whitfield Growdon
SurvivorNet Fact Checking and Medical Review Standards:  The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.All SurvivorNet articles adhere to the following standards:
  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated October 6th, 2023

Changing Landscape Of Ovarian Cancer Treatment: PARP Inhibitor Drugs Withdrawn For Some Indications

NOW
PLAYING
Don't Be Ignored: California Woman, 25, Has Symptoms Dismissed As 'Borderline Tumor'— The Second Opinion That Saved Her
NOW
PLAYING
'The Warrior Needs Rest Between Battles'-- Shannen Doherty, 52, Posts New Message-- 'She's Not The Princess That Needs Saving'
NOW
PLAYING
Tracy Herbert, 52, Is Enjoying Her 'Active Everyday Life' On Elahere
NOW
PLAYING
For Lung Cancer Patients With The EGFR Mutation: The Benefit of The Drug TAGRISSO Plus Chemotherapy
NOW
PLAYING
Metastatic Prostate Cancer: How Molecular Testing Can Impact Your Treatment Plan
NOW
PLAYING
Major Need Being Met: Immunotherapy-PARP Combo Can Significantly Slow Progression of Ovarian Cancer Without BRCA Mutations, Study Suggests

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... ovarian cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.